1C8L
SYNERGISTIC INHIBITION OF GLYCOGEN PHOSPHORYLASE A BY A POTENTIAL ANTIDIABETIC DRUG AND CAFFEINE
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | EMBL/DESY, HAMBURG BEAMLINE X11 |
Synchrotron site | EMBL/DESY, HAMBURG |
Beamline | X11 |
Temperature [K] | 100 |
Detector technology | IMAGE PLATE |
Collection date | 1999-04-15 |
Spacegroup name | P 43 21 2 |
Unit cell lengths | 126.690, 126.690, 115.300 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 26.500 - 2.300 |
R-factor | 0.21 |
Rwork | 0.210 |
R-free | 0.25700 |
Structure solution method | OTHER |
Starting model (for MR) | 3amv |
RMSD bond length | 0.007 |
RMSD bond angle | 24.400 * |
Data reduction software | DENZO |
Data scaling software | SCALEPACK |
Phasing software | X-PLOR |
Refinement software | X-PLOR (3.8) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 26.500 | 2.340 |
High resolution limit [Å] | 2.300 | 2.300 |
Rmerge | 0.078 | 0.375 |
Total number of observations | 183590 * | |
Number of reflections | 41698 | |
<I/σ(I)> | 10.5 | 2.6 |
Completeness [%] | 98.4 | 98.5 |
Redundancy | 4.4 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | unknown * | 6.7 | pH 6.70 |
Crystallization Reagents in Literatures
ID | crystal ID | solution | reagent name | concentration (unit) | details |
1 | 1 | 1 | enzyme | 29.1 (mg/ml) | |
2 | 1 | 1 | W1807 | 0.9 (mM) | |
3 | 1 | 1 | caffeine | 4.9 (mM) | |
4 | 1 | 1 | dithiothreitol | 3 (mM) | |
5 | 1 | 1 | BES | 10 (mM) | |
6 | 1 | 1 | EDTA | 0.1 (mM) | |
7 | 1 | 1 | sodium azide | 0.02 (%) |